Community Drug Management for Childhood Illness Assessment Manual

Le résumé fourni par la source

Both availability and rational use of pharmaceutical products are critical to successful implementation of the Integrated Management of Childhood Illness (IMCI) strategy of the World Health Organization (WHO) and the United Nations Children’s Fund (UNICEF). The IMCI health promotion strategy addresses the leading causes of global mortality among children under five years old: malaria diarrhea acute respiratory infection (ARI) measles and malnutrition. Most cases of malaria pneumonia and diarrhea are treated at home rather than in public health facilities. Thus efforts to reduce mortality and morbidity must focus on ensuring that correct treatment is available at the community level and that families seek obtain and appropriately use necessary medicines. This is an important aspect of the third component of IMCI: community IMCI which focuses on family and community practices. Yet in most settings little information exists to help district health officers managers of nongovernmental programs and other program planners design effective interventions for improving availability and use of medicines at the community level. The goal of assessing the availability and appropriate use of medicines at the community level is to provide district health officers and program managers with the information they need in order to make sound decisions about interventions for ensuring that appropriate medicines are available and properly used. Appropriate use of medicines may also help slow the development of antimicrobial resistance to medicines thereby reducing the likelihood that medicines will become ineffective. This manual provides guidance on how to assess community drug management for childhood illness (C-DMCI). In the chapters that follow you will learn how to prepare for administer analyze and interpret data from problem identification surveys of households and providers—the first step in ensuring that interventions target the right audience (i.e. caregivers and/or providers/drug vendors) and address the most critical problem areas. (excerpt)

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.